menu

Recapping the RxPONDER Trial at the 2020 San Antonio Breast Cancer Symposium

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Recapping the RxPONDER Trial at the 2020 San Antonio Breast Cancer Symposium

close
Recapping the RxPONDER Trial at the 2020 San Antonio Breast Cancer Symposium
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    How should we manage breast cancer patients with one to three positive lymph nodes and a low recurrence score? It’s a question we often encounter—and struggle with—in the clinic, but it’s also a question we finally know how to answer thanks to the RxPONDER trial. Here to share the trial’s key findings and what it could mean for pre and postmenopausal women is Dr. Lajos Pusztai, Professor of Medicine and Director of Breast Cancer Translational Research at Yale Cancer Center and Yale School of Medicine.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    How should we manage breast cancer patients with one to three positive lymph nodes and a low recurrence score? It’s a question we often encounter—and struggle with—in the clinic, but it’s also a question we finally know how to answer thanks to the RxPONDER trial. Here to share the trial’s key findings and what it could mean for pre and postmenopausal women is Dr. Lajos Pusztai, Professor of Medicine and Director of Breast Cancer Translational Research at Yale Cancer Center and Yale School of Medicine.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 2/25/21